Polypeptide and derivative and hydrogel thereof, and application of polypeptide and derivative and hydrogel in preparation of medicine for preventing and/or treating type I diabetes mellitus
A technology of derivatives and hydrogels, applied in the field of application of polypeptides and their derivatives and hydrogels, in the preparation of drugs for the prevention and/or treatment of type I diabetes, can solve problems such as difficult to achieve ideal results in clinical applications, Achieve good blood sugar load, clear product chemical structure, and reduce the effect of morbidity
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0071] (1) Peptide derivative Nap-G D f D f D Synthesis of Y
[0072] This embodiment provides a polypeptide whose sequence is shown in SEQ ID NO: 1 (Gly-D-Phe-D-Phe-D-Tyr, Gly-D-Phe-D-Phe-D-Tyr, G D f D f D The derivative of Y), its structural formula is:
[0073]
[0074] In the derivative, 2-naphthylacetic acid (Nap) is connected to the N-terminus of the polypeptide as a capping group to generate a derivative with a D configuration. For the convenience of description, the D configuration of the derivative is described as Nap-G in the present invention D f D f D Y.
[0075] The polypeptide derivative Nap-G of the present embodiment D f D f D Y was synthesized by Fmoc-short peptide solid-phase synthesis method. Specific steps are as follows:
[0076] 1) Weigh 0.5mmol 2-Cl-Trt resin in a solid-phase synthesizer, add 10mL of anhydrous dichloromethane (hereinafter referred to as DCM), place on a shaker and shake for 5min to fully swell the 2-Cl-Trt resin ;
[...
Embodiment 2
[0088] (1) Synthesis of polypeptide derivative Nap-GFFY
[0089] This embodiment provides a derivative of the polypeptide (Gly-Phe-Phe-Tyr, GFFY) whose sequence is shown in SEQ ID NO: 1, and its structural formula is:
[0090]
[0091] In the derivative, 2-naphthylacetic acid (Nap) is connected to the N-terminus of the polypeptide as a capping group to generate a derivative with an L configuration. For the convenience of description, the derivative is described as Nap-GFFY or Nap-G in the present invention L f L f L Y.
[0092] The polypeptide derivative Nap-GFFY of this example was synthesized by Fmoc-short peptide solid-phase synthesis method. Specific steps are as follows:
[0093] 1) Weigh 0.5mmol 2-Cl-Trt resin in a solid-phase synthesizer, add 10mL of anhydrous dichloromethane (hereinafter referred to as DCM), place on a shaker and shake for 5min to fully swell the 2-Cl-Trt resin ;
[0094] 2) Remove the DCM from the solid-phase synthesizer equipped with 2-Cl-T...
Embodiment 3
[0105] (1) Peptide derivative Nap- D f D Synthesis of F
[0106] This embodiment provides a polypeptide (D-Phe-D-Phe, D f D F) derivative, its structural formula is: And prepare the short peptide Nap- D f D F.
[0107] (2) Take 0.5mg Nap- D f D F was placed in a 1.5 ml glass bottle, added 500 microliters of PBS solution (pH=7.4), adjusted its pH value to 7.4 with sodium carbonate solution, heated to boiling to dissolve the compound completely, and cooled to room temperature to obtain Nap- D f D F short peptide hydrogel pharmaceutical preparations.
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com